title: The premium of a big pharma license deal.
authors.affiliation: Drug Development, School of Medicine, Trinity College Dublin, Ireland.
authors.forename: Kara E
authors.initials: KE
authors.lastname: O'Connell
authors.affiliation: Venture Valuation AG, Zurich, Switzerland.
authors.forename: Patrik
authors.initials: P
authors.lastname: Frei
authors.affiliation: 1] Drug Development, School of Medicine, Trinity College Dublin, Ireland [2] Venture Valuation AG, Zurich, Switzerland.
authors.forename: Kumlesh K
authors.initials: KK
authors.lastname: Dev
mesh_terms: D004345:Drug Industry / Q000191:economics*; D038622:Internationality; D008004:Licensure / Q000191:economics*; D004364:Pharmaceutical Preparations / Q000191:economics*; D018581:Technology Transfer
chemical_list: D004364:Pharmaceutical Preparations